PL3043814T3 - Antygen i sposób jego wytwarzania - Google Patents

Antygen i sposób jego wytwarzania

Info

Publication number
PL3043814T3
PL3043814T3 PL14776600T PL14776600T PL3043814T3 PL 3043814 T3 PL3043814 T3 PL 3043814T3 PL 14776600 T PL14776600 T PL 14776600T PL 14776600 T PL14776600 T PL 14776600T PL 3043814 T3 PL3043814 T3 PL 3043814T3
Authority
PL
Poland
Prior art keywords
antigen
production
Prior art date
Application number
PL14776600T
Other languages
English (en)
Inventor
Robin LÖVING
Jens Frauenfeld
Gunilla Karlsson HEDESTAM
Mathilda SJÖBERG
Henrik Garoff
Original Assignee
Salipro Biotech AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salipro Biotech AB filed Critical Salipro Biotech AB
Publication of PL3043814T3 publication Critical patent/PL3043814T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL14776600T 2013-09-13 2014-09-12 Antygen i sposób jego wytwarzania PL3043814T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1351057 2013-09-13
EP14776600.0A EP3043814B1 (en) 2013-09-13 2014-09-12 Antigen and method for production thereof
PCT/EP2014/069512 WO2015036549A1 (en) 2013-09-13 2014-09-12 Antigen and method for production thereof

Publications (1)

Publication Number Publication Date
PL3043814T3 true PL3043814T3 (pl) 2021-05-17

Family

ID=51626006

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14776600T PL3043814T3 (pl) 2013-09-13 2014-09-12 Antygen i sposób jego wytwarzania

Country Status (7)

Country Link
US (1) US10159729B2 (pl)
EP (1) EP3043814B1 (pl)
HU (1) HUE052677T2 (pl)
LT (1) LT3043814T (pl)
PL (1) PL3043814T3 (pl)
SI (1) SI3043814T1 (pl)
WO (1) WO2015036549A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2608857T3 (es) * 2012-12-18 2017-04-17 Salipro Biotech Ag Partículas Salipro
PL3043814T3 (pl) 2013-09-13 2021-05-17 Salipro Biotech AB Antygen i sposób jego wytwarzania
EP3284460A1 (en) 2016-08-19 2018-02-21 Salipro Biotech AG Saposin lipoprotein particles and libraries from crude membranes
KR102790861B1 (ko) 2017-09-18 2025-04-08 바이엘 헬쓰케어 엘엘씨 N-메틸글루카미드 및 그의 유도체를 사용한 바이러스 불활성화 방법
EP3725304A1 (en) 2019-04-15 2020-10-21 Salipro Biotech AB Production of salipro particles
CN110564734A (zh) * 2019-09-28 2019-12-13 中国医学科学院病原生物学研究所 一种埃及血吸虫重组融合蛋白ShSAP及其在血吸虫病免疫诊断中的应用
WO2022090752A1 (en) * 2020-10-26 2022-05-05 Pécsi Tudományegyetem Vaccine platform
WO2023001912A1 (en) 2021-07-22 2023-01-26 Salipro Biotech AB Methods for structure determination and drug design using salipro particles
EP4123307A1 (en) 2021-07-22 2023-01-25 Salipro Biotech AB Methods for structure determination and drug design using salipro particles

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652339A (en) 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins
US20020177551A1 (en) 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US7083958B2 (en) 2000-11-20 2006-08-01 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US7592008B2 (en) 2000-11-20 2009-09-22 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Membrane scaffold proteins
EP1345959B1 (en) 2000-11-20 2011-05-25 The Board Of Trustees Of The University Of Illinois Membrane scaffold proteins
US7622437B2 (en) 2000-11-20 2009-11-24 The Board Of Trustees Of The University Of Illinois Tissue factor compositions and methods
JP4777873B2 (ja) 2003-02-14 2011-09-21 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 親油性薬物送達ビヒクルおよびこれらの使用方法
US7834147B2 (en) 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
AU2004283078A1 (en) 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
US20080248565A1 (en) 2007-03-01 2008-10-09 Invitrogen Corporation Isolated phospholipid-protein particles
US20070117179A1 (en) 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
CA2666953A1 (en) 2006-10-20 2008-05-02 Children's Hospital Medical Center Spontaneous forming ellipsoidal phospholipid unilamellar vesicles
US8999320B2 (en) 2008-01-30 2015-04-07 The Rockefeller University Nanoscale bound bilayers, methods of use and production
US20120020878A1 (en) 2008-11-07 2012-01-26 Children's Hospital Medical Center Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems
WO2011044545A2 (en) 2009-10-09 2011-04-14 Sigalov Alexander B Methods and compositions for targeted imaging
US20120190609A1 (en) 2010-08-30 2012-07-26 Martin Bader Method for producing a lipid particle, the lipid particle itself and its use
US9585972B2 (en) 2011-05-09 2017-03-07 Sherry L. Thornton Method for imaging a site of arthritis in an animal
PL3043814T3 (pl) 2013-09-13 2021-05-17 Salipro Biotech AB Antygen i sposób jego wytwarzania

Also Published As

Publication number Publication date
US20160220664A1 (en) 2016-08-04
WO2015036549A1 (en) 2015-03-19
EP3043814B1 (en) 2020-12-02
EP3043814A1 (en) 2016-07-20
HUE052677T2 (hu) 2021-05-28
SI3043814T1 (sl) 2021-04-30
US10159729B2 (en) 2018-12-25
LT3043814T (lt) 2021-02-25

Similar Documents

Publication Publication Date Title
PT2967756T (pt) Aparelho de contenção e procedimento para a sua produção
EP3006415B8 (en) Method for producing nanocement and nanocement
EP2987650A4 (en) TIRE AND METHOD FOR PRODUCING THE SAME
GB201309057D0 (en) Method
HUE052677T2 (hu) Antigén és eljárás annak elõállítására
EP3045770A4 (en) FLAT RIBBON AND MANUFACTURING METHOD THEREFOR
GB201315777D0 (en) Novel method
IL239689A0 (en) A method for producing antibodies
EP2952895A4 (en) PROCESS FOR PRODUCING A MARKED ANTIBODY
GB201309928D0 (en) Method
SG11201507875RA (en) Protein production method
GB201301857D0 (en) Method
PL3069610T3 (pl) Ko-kryształ i sposób jego wytwarzania
GB201300409D0 (en) Method
IL241779A0 (en) Method for protein production
GB201309654D0 (en) Method
GB201305714D0 (en) Method
GB201301233D0 (en) Method
GB201310151D0 (en) Novel method
GB201301094D0 (en) Method
IL242505B (en) A method for producing specific oximes and oximeters
GB201301384D0 (en) Method for antibody production
GB201300945D0 (en) Improved snack product and method for its manufacture
GB201317888D0 (en) Method and product
GB201300358D0 (en) Method and product